How High Court Teva Ruling Will Affect Patent Litigants
In a 7-2 decision issued on Jan. 20, 2015, the U.S. Supreme Court, in Teva Pharmaceuticals USA Inc. v. Sandoz Inc., held that the Federal Circuit must review factual findings underlying claim...To view the full article, register now.
Already a subscriber? Click here to view full article